BioAdvance
PE/Buy-Out · Conshohocken (United States)
Sign up free to access full profile and submit your pitch.
About
BioAdvance is a venture capital firm specializing in seed, start up, early stage, series A and emerging growth investments. The firm seeks to invest in life sciences, therapeutic agents, diagnostics, health information technology, medical devices, digital health, research tools, and platform technologies focused on human health. It prefers to invest in Mid-Atlantic companies mainly based in the Southeastern region of Pennsylvania, New York, New Jersey, Delaware, Maryland, Virginia, West Virginia, and Washington, D.C. in the United States. The firm initial investment size typically ranges between $0.5 million to $1.5 million and can commit up to $5 million over the lifetime of companies with the potential to significantly improve human health. It consider leading rounds between $0.5 million and $5 million, BioAdvance was founded in 2003 and is based in Conshohocken, Pennsylvania.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.